Biography
Allison Webber, M.D. joined UCSF Department of Medicine- Nephrology in 2009 after completing her training at the New York Presbyterian Hospital- Weill Cornell Medical Center in General and Transplant Nephrology. She has had various leadership positions, including her role as the post-kidney transplant clinic director from 2010-2018.
Dr. Webber runs a monthly kidney transplant conference with the general and transplant nephrology fellows where transplant-related concepts including: immunosuppressive drugs, rejection, transplant histopathology, immunology, and infectious complications are reviewed.
Her research interests include immune monitoring and antibody mediated rejection in kidney transplantation, and she is a co-principal investigator or co-investigator on several industry and government sponsored studies in these areas.
Recently she has taken an interest in developing a program for kidney transplantation for patients with end stage renal disease from multiple myeloma. Partnering with her oncology colleagues, she has developed a protocol for transplantation specifically for this patient population.
Dr. Webber runs a monthly kidney transplant conference with the general and transplant nephrology fellows where transplant-related concepts including: immunosuppressive drugs, rejection, transplant histopathology, immunology, and infectious complications are reviewed.
Her research interests include immune monitoring and antibody mediated rejection in kidney transplantation, and she is a co-principal investigator or co-investigator on several industry and government sponsored studies in these areas.
Recently she has taken an interest in developing a program for kidney transplantation for patients with end stage renal disease from multiple myeloma. Partnering with her oncology colleagues, she has developed a protocol for transplantation specifically for this patient population.
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
New York Presbyterian Hospital Weill Cornell Medical Center | Transplant Medicine | 6/2009 | |
New York Presbyterian Hospital Weill Cornell Medical Center | Nephrology | 6/2008 | |
New York Downtown Hospital | Chief Resident | 6/2006 | |
NY Presbyterian Hospital Weill Cornell Medical Center | Internal Medicine Residency | 6/2005 | |
Albert Einstein College of Medicine | M.D. | Medicine | 6/2002 |
University of Pennsylvania | B.A. | English/Pre-Med | 5/1997 |
Board Certifications
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Nephrology Subspecialty
Clinical Expertise
Kidney Transplantation
Transplant Nephrology
Chronic Kidney Disease
End Stage Renal Disease (Kidney Failure)
Living Kidney Donor Transplantation
Acute Kidney Injury
Clinical Trials
- NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients (NCT01771705)Related Conditions: Kidney Transplant, Transplants| Start Date: | End Date:
- Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients (NCT01624948)Related Conditions: BK Virus, Kidney Transplant, Transplants| Start Date: | End Date:
Research Interests
Immune monitoring
Urinary biomarkers
Primary nonfunction
Post-transplantation collapsing glomerulopathy
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 22
- Diabetes Insipidus in Deceased Donors and Outcomes in Kidney Transplant Recipients.| | View in PubMed
- Transplant Onconephrology in Patients With Kidney Transplants.| | View in PubMed
- Outcomes of kidney transplant recipients with ESKD due to plasma cell dyscrasia: A case series.| | View in PubMed
- COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions.| | View in PubMed
- A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized Recipients.| | View in PubMed
- Successful Deceased Donor Kidney Transplantation of Highly Sensitized Candidates Across Positive Cross Match and Strong Donor-Specific HLA-DP Antibodies without Desensitization.| | View in PubMed
- Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial.| | View in PubMed
- Kidney Transplantation for Kidney Failure Due to Multiple Myeloma: Case Reports.| | View in PubMed
- An Update on Calcineurin Inhibitor-Free Regimens: The Need Persists, but the Landscape has Changed.| | View in PubMed
- An unusual case of ischemic nephropathy.| | View in PubMed
- Future Pathways for Immune Manipulation.| | View in PubMed
- Everolimus Conversion to Treat BK Virus Infection in Renal Transplant Recipients: Interim Analysis of a Pilot Study.| | View in PubMed
- Feasibility of Adjustment of Immunosuppression Based On NFAT-Dependent Cytokine Gene Expression Levels in Kidney Transplant Patients - Interim Analysis.| | View in PubMed
- Pharmacodynamic Monitoring of NFAT- Regulated Gene Expression and P70S6 Kinase Activity in Kidney Transplant Patients With BKV Infection.| | View in PubMed
- Prediabetic living kidney donors have preserved kidney function at 10 years after donation.| | View in PubMed
- Fatal transplant-associated west nile virus encephalitis and public health investigation-california, 2010.| | View in PubMed
- Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.| | View in PubMed
- Mean arterial blood pressure while awaiting kidney transplantation is associated with the risk of primary nonfunction.| | View in PubMed
- Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.| | View in PubMed
- Novel strategies in immunosuppression: issues in perspective.| | View in PubMed
- Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient.| | View in PubMed
- The Case | Triple acid-base disorder after drug abuse.| | View in PubMed